CIRC Subsidiary Advances Most cancers Therapy in China


China Isotope & Radiation Corp. (HK:1763) has launched an replace.

China Isotope & Radiation Company’s subsidiary, CNNC Chengying, has achieved a milestone by acquiring a registration certificates from China’s Nationwide Medical Merchandise Administration for its modern Gamma-ray Stereotactic Radiotherapy System. This superior medical gear, powered by domestically-produced cobalt-60, guarantees to reinforce the effectivity and precision of most cancers therapies in China. The corporate anticipates that this achievement will help China’s ‘Wholesome China 2030’ initiative and bolster nationwide well being safety.

For additional insights into HK:1763 inventory, take a look at TipRanks’ Inventory Evaluation web page.

Hot Topics

Related Articles